In this specific case therefore, the optimal vaccine may be, simply a minimal high affinity agonist CD8+ T Cell epitope conjugated directly to the nanoparticle, similarly to our previous studies using malaria high affinity agonist peptides with PSNPs (18). This evidence concerns the gene CD8A and malaria.